Key facts
- SHINE Technologies’s last known valuation is $368.1M (Jun 2019).
- It has raised $1.0B across 2 recorded rounds; the latest was PE Growth/Expansion ($138.4M) in Oct 2023.
- Notable investors include Alumni Ventures, Fidelity Management & Research Company, U.S. Department of Energy, Baillie Gifford, Koch Disruptive Technologies — 24 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for SHINE Technologies
Funding rounds
2 roundsAbout SHINE Technologies
Developer of fusion-based technology solutions that produce neutron sources for industrial imaging applications, including neutron radiography, radiation-effects testing, and fusion material research, and is developing technology for nuclear waste recycling. The company produces medical isotopes using fusion-based neutron sources and manufactures medical isotopes, including lutetium-177, for diagnostic and therapeutic applications.
- Industry
- Pharmaceuticals
- Sector
- Healthcare
- HQ
- Janesville, WI, United States
- Founded
- 2010
- Employees
- 400
- Website
- shinefusion.com/
- Ownership
- Privately Held (backing)
SHINE Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SHINE Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SHINE Technologies in its N-PORT filings yet. We sweep new filings monthly.